Search by Drug Name or NDC

    NDC 42364-0011-02 vanquish 194; 227; 33 mg/1; mg/1; mg/1 Details

    vanquish 194; 227; 33 mg/1; mg/1; mg/1

    vanquish is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by DSE Healthcare Solutions, LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 42364-0011
    Product ID 42364-0011_491245d9-8bda-4cf3-a934-49757a54d81e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name vanquish
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen, aspirin, and caffeine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 194; 227; 33
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name DSE Healthcare Solutions, LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 42364-0011-02 (42364001102)

    NDC Package Code 42364-0011-2
    Billing NDC 42364001102
    Package 1 BOTTLE in 1 CARTON (42364-0011-2) / 120 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2018-07-15
    NDC Exclude Flag N
    Pricing Information N/A
    << 42364-0011-01 42367-0521-25 >>

    Contents